Fav-aisync

Sponsor Clinical Eligibility Verification | AiSync

AiSync — Powered by iHealthSync

AiSync for Sponsors

Protect Your
Enrollment Investment.

Patient referrals are the beginning.
Clinical evidence determines what happens next.

AiSync helps clinical trial sponsors close the gap between patient recruitment and site screening. It combines protocol-aligned clinical verification, targeted medical record retrieval, and source-supported eligibility assessments.

Discuss Your Study View Independent Results
  2. Patient Referrals
    Identify potential participants

    From CROs, recruitment partners, sites and other channels

  3. Clinical Verification
    Confirm & complete the clinical evidence

    National exchanges, provider-direct retrieval, gap resolution

  4. Site Review
    Enable informed screening decisions

    Protocol-aligned, source-cited evidence for investigator review

  5. Randomization
    More efficient enrollment execution

    Reduce avoidable screen failures and keep your study on track

Enrollment funnel: patient referrals, clinical verification, site review, and randomization.

The hidden cost of unverified referrals

The Cost of Recruitment
Doesn’t End With the Referral.

Every promising referral triggers downstream work. When critical medical evidence is missing or contradictory, the consequences affect research sites, CRO operations, patient experience, and ultimately sponsor budgets.

  1. 1

    Patient Recruitment

    Interested patients are identified and referred from multiple channels.

  2. 2

    Evidence Gaps

    Referrals may lack complete, current, or consistent clinical evidence.

  3. 3

    Site Burden

    Sites spend time requesting, reviewing, and chasing missing records.

  4. 4

    Sponsor Impact

    Screening inefficiencies increase costs, slow enrollment, and add execution risk.

More referrals don’t always lead to more enrolled patients.

Without complete clinical evidence, promising candidates often become screen failures — creating avoidable costs, operational inefficiencies, and delays in meeting enrollment goals.

The AiSync advantage

Find the Missing Evidence
Before It Becomes a Screening Problem.

AiSync helps sponsors strengthen the path from referral to screening. It introduces earlier clinical verification, targeted provider-direct retrieval, and protocol-aligned evidence assessment before downstream screening costs escalate.

Traditional Approach

Referral first. Evidence later.

  1. Self-reported prescreening

  2. Limited site EMR data

  3. Outside records requested after referral

  4. Potential exclusions discovered late

  5. More uncertainty at screening

Higher downstream screening burden

With AiSync

Evidence earlier. Better-informed screening.

  1. Study-specific authorization

  2. Digital access + provider-direct retrieval

  3. Protocol-aligned evidence assessment

  4. Targeted evidence-gap closure and reassessment

  5. Page-cited Clinical Summary for site review

Earlier visibility into eligibility risks

AiSync uses available digital clinical information as a starting point — then pursues the provider-held evidence the protocol requires.

The result is a clearer clinical picture before costly downstream screening work expands.

Independent evaluation. Measurable results.

Independent Evaluation.
Meaningful Enrollment Improvements.

A retrospective before-and-after evaluation, conducted by an independent consulting firm commissioned by AES (a PPD-owned organization), analyzed real-world study data across multiple therapeutic areas after iHealthSync implementation.

  • 52,386
    Patients analyzed
  • 1,672
    Research sites
  • 9
    Clinical studies
  • 29
    Months evaluated
  • +200%+
    Reported randomization improvement
  • +130%+
    Reported consent improvement
  • 18:1 → 3:1
    Screen-fail ratio improvement
  • 26-36 → 1–3
    Days to evaluation (from referral to review)
Reported p-value: 0.001

A retrospective before-and-after evaluation conducted by an independent consulting firm commissioned by AES, a PPD-owned organization. iHealthSync was unaware the evaluation was underway and did not participate in its execution.

Sponsor economics

What Could More Efficient Screening Be Worth to Your Study?

By identifying and pursuing missing clinical evidence earlier, AiSync can help reduce avoidable screen failures and the associated costs, operational burden, and delays.

Illustrative economics based on historical COPD case

864370222 144
  • Candidates processed
  • Referred to sites
  • Formally screened
  • Randomized

Preliminary Evaluation Efficiency

$252,000

1,008 baseline-equivalent evaluations × $250 per evaluation

Avoided Formal Screen Costs

~$140,000

Approximately 40 baseline-equivalent screening episodes × $3,500 per episode

Explore your scenario

Illustrative Model

Gross modeled efficiency

$392,000
$252,000Preliminary evaluation
~$140,000Avoided formal-screen costs

Fewer avoidable screen failures. More efficient use of your enrollment investment.

These figures are based on a historical COPD program and are not a calculation of realized savings or a guaranteed return. Actual results, costs, and impact will vary by study.

Explore a Study-Specific Scenario

Implementation & integration

No Need to Replace Your CRO, Recruitment Partners, or Site Workflows.

AiSync integrates into your existing enrollment ecosystem and adds a clinical verification layer between patient identification and site screening.

Your existing recruitment channels

Keep the partners and strategies that work for you.

  • CROs
  • Recruitment partners
  • Digital campaigns
  • Patient advocacy groups
  • Site networks
  • EMR / database outreach

Clinical verification layer

We retrieve, verify, and organize the right clinical evidence before it reaches your sites.

  1. 1

    Provider-Direct Retrieval

    Collects missing medical records from non-exchanged providers.

  2. 2

    Evidence-Gap Resolution

    Evaluates evidence against protocol inclusion/exclusion criteria.

  3. 3

    AiSync Clinical Summary

    A clear, source-cited summary with PASS / PASS WITH EXCEPTION / FAIL.

Research site review

Sites receive clinically verified, organized patient packages.

  • Complete, relevant clinical evidence
  • Protocol-aligned summary
  • Source-cited hyperlinks to records
  • Investigator retains final eligibility authority

  • Simple to Implement

    Works with your existing systems and workflows.

  • Flexible Delivery

    Via the iHS portal or partner API.

  • Designed to Enhance

    Your recruitment strategy and site performance.

Your Enrollment Strategy
Deserves Better Clinical Evidence.

Whether you’re designing a new protocol, reviewing recruitment performance, or addressing avoidable screening inefficiencies in an active trial, AiSync helps identify where clinical verification can create measurable value.

Bring us your protocol. We’ll help identify where clinical verification can create value.

Discuss Your Study
  • Study-specific assessment
  • Integration planning
  • Clinical evidence strategy
Scroll to Top